Effect of InterMune, Inc.'s (JOBS) Lung Drug, Pirfenidone Unclear; Shares Soar Despite FDA Concerns

Reuters -- U.S. health regulatory staff are concerned that studies of InterMune Inc’s (ITMN.O) drug to treat lung scarring may not be enough to prove the treatment works and may point to safety issues, according to documents made public on Friday.